Intraosseous infusion of liposome‐encapsulated hemoglobin (HbV) acutely prevents hemorrhagic anemia‐induced lethal arrhythmias, and its efficacy persists with preventing proarrhythmic side effects in the subacute phase of severe hemodilution modelBonpei Takase, Hiromi Sakai, Manabu Kinoshita et al.|Artificial Organs|2022Cited by 7
Liposome‐encapsulated hemoglobin rescues hemorrhagic shock heart through anti‐ischemic and anti‐arrhythmogenic effects on myocardium in repetitive 65% bleeding rat modelBonpei Takase, Hiromi Sakai, Takeshi Adachi et al.|Artificial Organs|2024Cited by 2
Abstract 202: Liposome-Encapsulated Hemoglobin (HbV) Rescues Hemorrhagic Shock Heart Through Anti-Ischemic and Anti-Arrhythmogenic Effects on Myocardium in Repetitive 65% Bleeding Rat ModelBonpei Takase, Hiromi Sakai, Yuko Higashimura et al.|Circulation|2023Cited by 1
Abstract Sa205: Resuscitation and Antiarrhythmic Effects of Artificial Oxygen Carrier of HbV in Perioperative Severe Hemorrhagic Shock during Total Pneumonectomy ModelBonpei Takase, Hiromi Sakai, Yuko Higashimura et al.|Circulation|2024Cited by 0
Abstract Sun204: Artificial Oxygen Carrier (HbV) Ameliorates Prognosis through Persistently Improving Arrhythmogenicity, LV dysfunction, Systemic Organ Damages in Hemorrhagic Shock during PneumonectomyBonpei Takase, Masayoshi Nagata, Manabu Kinoshita et al.|Circulation|2025Cited by 0